SnapShot: Renal Cell Carcinoma

Samra Turajlic; James Larkin; Charles Swanton

doi:10.1016/j.cell.2015.11.026

SnapShot: Renal Cell Carcinoma

Cell. 2015 Dec 3;163(6):1556-1556.e1. doi: 10.1016/j.cell.2015.11.026.

Authors

Samra Turajlic¹, James Larkin², Charles Swanton³

Affiliations

¹ The Francis Crick Institute, 44 Lincoln's Inn Fields, London WC2A 3LY, UK; Renal Unit, The Royal Marsden Hospital, London SW3 6JJ, UK.
² Renal Unit, The Royal Marsden Hospital, London SW3 6JJ, UK.
³ The Francis Crick Institute, 44 Lincoln's Inn Fields, London WC2A 3LY, UK.

PMID: 26638079
DOI: 10.1016/j.cell.2015.11.026

Abstract

This SnapShot summarizes current knowledge about the key features in mutational landscape, major pathways, and tumor evolution and heterogeneity in renal cell carcinoma, as well as the most recent advances in therapeutic development. To view this SnapShot, open or download the PDF.

MeSH terms

Antineoplastic Agents / therapeutic use
Carcinoma, Renal Cell / drug therapy
Carcinoma, Renal Cell / genetics
Carcinoma, Renal Cell / pathology*
Humans
Kidney Neoplasms / drug therapy
Kidney Neoplasms / genetics
Kidney Neoplasms / pathology*
Mutation

Substances

Antineoplastic Agents

Abstract

MeSH terms

Substances

Grants and funding